Bristol Myers Squibb (BMS)
Bristol Myers Squibb (BMS) is a global biopharmaceutical company that discovers, develops, and delivers innovative medicines to help patients prevail over serious diseases. It is one of the world's largest pharmaceutical companies, consistently ranking on the Fortune 500 list, with a primary focus on oncology, cardiovascular, immunology, and fibrotic diseases.
Brand Authority Index (BAI): 92/100
Archetype: Challenger
Category: Healthcare
https://optimly.ai/brand/bristol-myers-squibb-bms
Last analyzed: April 10, 2026
Verified from Bristol Myers Squibb (BMS) website
Founded: 1887 (Bristol-Myers), 1858 (Squibb), 1989 (Merger)
Headquarters: Princeton, New Jersey, USA
Buyer Intent Signals for Bristol Myers Squibb (BMS)
Problems this brand solves
- In-house Research Institutions: Large academic medical centers or specialized hospitals developing their own cell therapies or treatment protocols.
- Full-service CROs: Hiring contract research organizations (CROs) to handle drug discovery and clinical trials rather than a full-service biopharma partner.
Buyers search for
- top oncology pharmaceutical companies
- who makes Eliquis
- leading immunology drug developers
- biopharma companies in New Jersey
- best treatments for schizophrenia 2024
- Generic Manufacturers: Relying on older generations of generic drugs or non-patented treatments after a brand-name drug's patent expires.